BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2457788)

  • 1. Methylxanthine inhibitors of phosphodiesterases.
    Wells JN; Miller JR
    Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
    Wells JN; Kramer GL
    Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
    [No Abstract]   [Full Text] [Related]  

  • 3. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
    Van Inwegen RG; Salaman P; St Georgiev V; Weinryb I
    Biochem Pharmacol; 1979 Apr; 28(8):1307-12. PubMed ID: 87199
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
    Glass WF; Moore JB
    Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle.
    Polson JB; Krzanowski JJ; Anderson WH; Fitzpatrick DF; Hwang DP; Szentivanyi A
    Biochem Pharmacol; 1979 Apr; 28(8):1391-5. PubMed ID: 87201
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclic nucleotide phosphodiesterase activities of the embryonic chick ovary.
    Teng CT; Buchler B; Teng CS
    Gen Comp Endocrinol; 1981 Aug; 44(4):409-17. PubMed ID: 6167486
    [No Abstract]   [Full Text] [Related]  

  • 8. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE; Lakey T; Houslay MD
    Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of cyclic nucleotide phosphodiesterases by analogues of 1-methyl-3-isobutylxanthine.
    Kramer GL; Garst JE; Mitchel SS; Wells JN
    Biochemistry; 1977 Jul; 16(15):3316-21. PubMed ID: 196632
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurements of cyclic AMP and cyclic GMP phosphodiesterase activity in isolated tubular segments.
    Jackson BA; Edwards RM; Dousa TP
    Kidney Int; 1980 Oct; 18(4):512-8. PubMed ID: 6164816
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds.
    Francis SH; Sekhar KR; Ke H; Corbin JD
    Handb Exp Pharmacol; 2011; (200):93-133. PubMed ID: 20859794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
    Nemoz G; Prigent AF
    Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase by cyclic nucleotides and their analogues and various drugs [proceedings].
    Butt NM; Saeed SA; Collier HO
    Biochem Soc Trans; 1980 Jun; 8(3):380-1. PubMed ID: 6249674
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of inhibitors of cyclic nucleotide phosphodiesterases on electrical and contractile activity of smooth muscle cells.
    Kovalev IV; Popov AG; Baskakov MB; Minochenko IL; Kilin AA; Borodin YL; Anfinogenova YD; Kapilevich LV; Medvedev MA
    Bull Exp Biol Med; 2002 Jan; 133(1):38-40. PubMed ID: 12170302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
    Ahluwalia GS; Rhoads AR
    Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
    Kass DA
    Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.
    Nicholson CD; Shahid M
    Pulm Pharmacol; 1994 Feb; 7(1):1-17. PubMed ID: 8003849
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of human lung cyclic nucleotide phosphodiesterases by proxyphylline, theophylline and their metabolites.
    Selvig K; Bjerve KS
    Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):250-2. PubMed ID: 6291318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical stimulation by 1-methyl-3-isobutylxanthine of rat liver cyclic AMP phosphodiesterase activity.
    Erneux C; Miot F; Boeynaems JM; Dumont JE
    FEBS Lett; 1982 Jun; 142(2):251-4. PubMed ID: 6179796
    [No Abstract]   [Full Text] [Related]  

  • 20. Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.
    Worby A; Mensah LM; Murray KJ
    Biochem Soc Trans; 1992 May; 20(2):129S. PubMed ID: 1327896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.